• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解读感染中的实验室检查:理解重症监护病房患者脓毒症和全身炎症反应综合征中的生物标志物

Interpreting Laboratory Tests in Infection: Making Sense of Biomarkers in Sepsis and Systemic Inflammatory Response Syndrome for Intensive Care Unit Patients.

作者信息

Martin Jennifer B, Badeaux Jennifer E

机构信息

Nurse Anesthesia Program, School of Nursing, Louisiana State University Health Sciences Center, 1900 Gravier Street, New Orleans, LA 70112, USA.

Nurse Anesthesia Program, School of Nursing, Louisiana State University Health Sciences Center, 1900 Gravier Street, New Orleans, LA 70112, USA.

出版信息

Crit Care Nurs Clin North Am. 2017 Mar;29(1):119-130. doi: 10.1016/j.cnc.2016.09.004. Epub 2016 Dec 14.

DOI:10.1016/j.cnc.2016.09.004
PMID:28160953
Abstract

Sepsis and severe sepsis are leading causes of death in the United States and the most common causes of death among critically ill patients in noncoronary intensive care units. Diagnosis of infection and sepsis is a subjective clinical judgment based on the criteria for systemic inflammatory reaction, which is highly sensitive, not specific, and often misleading in intensively treated patients. Biomarkers are emerging as adjuncts to traditional diagnostic measures. No biomarkers have sufficient specificity or sensitivity to be routinely used in clinical practice, but they can aid in the diagnosis and treatment of infection versus inflammation.

摘要

脓毒症和严重脓毒症是美国的主要死因,也是非冠心病重症监护病房中重症患者最常见的死因。感染和脓毒症的诊断是基于全身炎症反应标准的主观临床判断,该标准高度敏感但不具特异性,在接受强化治疗的患者中常常具有误导性。生物标志物正逐渐成为传统诊断方法的辅助手段。目前尚无生物标志物具有足够的特异性或敏感性可常规用于临床实践,但它们有助于区分感染与炎症,以指导诊断和治疗。

相似文献

1
Interpreting Laboratory Tests in Infection: Making Sense of Biomarkers in Sepsis and Systemic Inflammatory Response Syndrome for Intensive Care Unit Patients.解读感染中的实验室检查:理解重症监护病房患者脓毒症和全身炎症反应综合征中的生物标志物
Crit Care Nurs Clin North Am. 2017 Mar;29(1):119-130. doi: 10.1016/j.cnc.2016.09.004. Epub 2016 Dec 14.
2
Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?对复杂长期 ICU 患者的脓毒症生物标志物进行日常监测:能否支持治疗决策?
Minerva Anestesiol. 2010 Oct;76(10):814-23. Epub 2010 Jul 1.
3
Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.使用联合生物标志物算法识别疑似脓毒症但细菌感染可能性极低的医学重症监护病房患者。
Antimicrob Agents Chemother. 2015 Oct;59(10):6494-500. doi: 10.1128/AAC.00958-15. Epub 2015 Aug 3.
4
The utility of procalcitonin in critically ill trauma patients.降钙素原在危重症创伤患者中的应用。
J Trauma Acute Care Surg. 2012 Aug;73(2):413-8; discussion 418. doi: 10.1097/TA.0b013e31825ff5b7.
5
The diagnostic value of serum leptin monitoring and its correlation with tumor necrosis factor-alpha in critically ill patients: a prospective observational study.危重症患者血清瘦素监测的诊断价值及其与肿瘤坏死因子-α的相关性:一项前瞻性观察研究。
Crit Care. 2010;14(2):R33. doi: 10.1186/cc8911. Epub 2010 Mar 15.
6
Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome.降钙素原和C反应蛋白作为危重症儿童全身炎症反应综合征发作时细菌感染的标志物。
Pediatr Crit Care Med. 2008 Jul;9(4):407-13. doi: 10.1097/PCC.0b013e31817285a6.
7
Assessing, treating and managing patients with sepsis.评估、治疗和管理脓毒症患者。
Nurs Stand. 2005;19(50):56-64. doi: 10.7748/ns2005.08.19.50.56.c3942.
8
Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.患有脓毒症和全身炎症反应综合征的早产及足月危重新生儿中的可溶性CD14亚型(sCD14-ST)前降钙素。
Clin Chim Acta. 2015 Dec 7;451(Pt A):65-70. doi: 10.1016/j.cca.2015.07.025. Epub 2015 Jul 29.
9
Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin.预测新发发热危重症患者高、低危微生物感染的新旧生物标志物:降钙素原的作用。
J Infect. 2012 May;64(5):484-93. doi: 10.1016/j.jinf.2012.01.002. Epub 2012 Jan 8.
10
[Sepsis].[脓毒症]
Wien Klin Wochenschr. 2006 Sep;118(17-18 Suppl 2):93-106; quiz 107-8. doi: 10.1007/s11812-006-0007-4.

引用本文的文献

1
The role of nanotechnology-based approaches for clinical infectious diseases and public health.基于纳米技术的方法在临床传染病和公共卫生中的作用。
Front Bioeng Biotechnol. 2023 Apr 3;11:1146252. doi: 10.3389/fbioe.2023.1146252. eCollection 2023.
2
Does Neutrophil-to-lymphocyte Ratio at Admission Predict Severity and Mortality in COVID-19 Patients? A Systematic Review and Meta-analysis.入院时中性粒细胞与淋巴细胞比值能否预测COVID-19患者的严重程度和死亡率?一项系统评价和荟萃分析。
Indian J Crit Care Med. 2022 Mar;26(3):361-375. doi: 10.5005/jp-journals-10071-24135.
3
Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p.
丹皮酚通过上调 miR-339-5p 靶向 HMGB1 减轻炎症反应。
Sci Rep. 2019 Dec 18;9(1):19370. doi: 10.1038/s41598-019-55980-4.
4
Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study.中性粒细胞与淋巴细胞比值在重症监护病房脓毒症早期诊断中的应用:一项病例对照研究
Rev Bras Ter Intensiva. 2019;31(1):64-70. doi: 10.5935/0103-507X.20190010. Epub 2019 Mar 21.
5
MicroRNA-365 regulates the occurrence and immune response of sepsis following multiple trauma via interleukin-6.微小RNA-365通过白细胞介素-6调节多发伤后脓毒症的发生及免疫反应。
Exp Ther Med. 2018 Oct;16(4):3745-3751. doi: 10.3892/etm.2018.6647. Epub 2018 Aug 22.
6
Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing.使用全基因组测序对英国六家医院艰难梭菌感染控制情况的比较
Clin Infect Dis. 2017 Aug 1;65(3):433-441. doi: 10.1093/cid/cix338.